Witness the power of images to change the world: The First SmallRig Awards Announce 22 Global Winners
SHENZHEN, China, June 4, 2025 /PRNewswire/ -- The 2025 International Image Culture Week kicked off in Shenzhen with the highly anticipated 2025 SmallRig Awards Ceremony, where 22 prestigious awards were presented to exceptional global creators. The...
"Xiamen Day" Successfully Held at Expo 2025 Osaka China Pavilion, Fostering a New Era of Multifaceted Collaboration
OSAKA, Japan, June 3, 2025 /PRNewswire/ -- From May 31 to June 1, 2025, "Xiamen Day" captivated audiences at the China Pavilion of Expo 2025 Osaka. Under the theme "Facing the Sea, Flowers Blooming in Four Seasons" and guided by the principles of...
Investbanq Reflects on the Road Ahead After a Successful Meet the Drapers Finale
SINGAPORE, June 3, 2025 /PRNewswire/ -- As the season seven finale of the global startup reality show Meet the Drapers aired, Singapore-based fintech startup Investbanq took a moment to reflect on what the experience meant—not just as a recognition...
2025 ASCO ｜Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer
YANTAI, China, June 3, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beijing Cancer Hospital presented the results of a Phase 2 clinical study conducted in China evaluating...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma
SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)
SHANGHAI, May 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by its...
"Made-in-Shanghai" Takes China-chic Brands and Shanghai's Fashion Ecosystem to Osaka
OSAKA, Japan, May 29, 2025 /PRNewswire/ -- More than a fascinating array of creative exhibits, pop-up stores and twin-city forums, "Made-in-Shanghai" is an international showcase of Shanghai's fashion ecosystem. On May 21st to 25th, the sixth...
Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma
EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. The Fast Track Designation highlights the potential of...
Japan-Tag Düsseldorf/NRW 2025: Around 380,000 visitors celebrated a festival of Japanese culture and encounters in Düsseldorf - Spectacular finale with traditional Japanese fireworks
DÜSSELDORF, Germany, May 27, 2025 /PRNewswire/ -- The 22nd Japan-Tag Düsseldorf/NRW was once again a complete success: despite the changeable weather, around 380,000 visitors from Germany and abroad traveled to Düsseldorf's city centre on May 24th...
Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies
SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented at the...